THE PENINSULA’S GLOBAL “ART IN RESONANCE” PROGRAMME 2025 SHOWCASES GROUNDBREAKING CONTEMPORARY ARTWORKS
Three commissioned artworks — including one in partnership with the Victoria and…
Novartis receives third FDA approval for oral Fabhalta (iptacopan) the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first…
Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
CASTRES, France, CAMBRIDGE, Massachusetts and BASEL, Switzerland, March 12, 2025 /PRNewswire/ --…
MUFG Bank, Ltd. announces Risk-Adjusted Capital Ratio Based on the Basel 3 Standards for the Third Quarter Ended December 31, 2024
TOKYO--(BUSINESS WIRE)--MUFG hereby announces the risk-adjusted capital ratio based on the Basel…
Syngenta Group adds new independent director to its Board of Directors
Alf Barrios is an international executive with extensive experience in the natural…
HABANOS, S.A. UNVEILED RAMN ALLONES ABSOLUTOS EDICIN LIMITADA 2024 IN A WORLD EXCLUSIVE EVENT IN BASEL
Habanos, S.A., together with Intertabak AG, the exclusive distributor of Habanos in…
Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU
As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor…
Sandoz to confirm strategic roadmap and highlight pipeline catalysts at 43rd Annual J.P. Morgan Healthcare Conference
MEDIA RELEASE Strong first year as standalone company; global leader Sandoz uniquely…
Artificial intelligence is speeding up the development of the next generation of biostimulants
Syngenta Crop Protection and TraitSeq announce a pioneering collaboration which could help…
Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA
Ad hoc announcement pursuant to Art. 53 LR The Phase III STEER…